未登录Prognostic Implications of HPV Cell-Free DNA Serial Testing During Follow-Up of p16 Positive Oropharyngeal Squamous Cell Carcinoma After Curative-Intent Treatmentp16阳性口咽鳞状细胞癌在根治性治疗后的随访期间，人乳头瘤病毒细胞游离DNA系列检测的预后意义
Salati, V.; Adamowicz, M.; McKean, L.; Noble, D.; Srinivasan, D.; MacKenzie, J.; Linton, S.; Callaghan, C.; Robert, C.; Cuschieri, K.; Conn, B.; Hay, A.; Aitman, T. J.; Nixon, I. J. .png)
分享.png)
收藏分享 收藏 POPPY: A phase II trial to assess the efficacy and safety profile of pembrolizumab in patients of performance status 2 with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M HNSCC)POPPY：一项评估帕博利珠单抗在体力状况评分为2分的复发性/转移性头颈鳞癌（R/M HNSCC）患者中的有效性和安全性特征的II期临床试验Forster, M. D.; Mason, J.; Moleron, R.; Sacco, J. J.; Beasley, M.; Ferreira, M. Reis; Srinivasan, D.; Yip, K.; Stewart, G.; Chiu, K.; Ward, A.; Metcalf, R.; Adedoyin, T.; Begum, R.; Chiwewe, M.; Poole, K.; Spanswick, V.; Pathak, Y.; Counsell, N.; Rashid, M. K. 分享 收藏 分享 收藏 The UK Divide: Does Having a Pembrolizumab- Chemotherapy Option in Head and Neck Cancer Matter? Real-world Experience of First-line Palliative Pembrolizumab Monotherapy and Pembrolizumab- Chemotherapy Combination in Scotland英国的分歧: 在头颈癌中使用Pembrolizumab化疗方案是否重要？苏格兰一线姑息性Pembrolizumab单药治疗和Pembrolizumab-化疗联合治疗的真实世界经验Thapa, A.; Cowell, A.; Peters, A.; Noble, D. J.; James, A.; Lamb, C.; Grose, D.; Vohra, S.; Schipani, S.; Mactier, K.; Mackenzie, J.; Srinivasan, D.; Laws, K.; Moleron, R.; Niblock, P.; Soh, F. -Y.; Paterson, C.; Wilson, C. 分享 收藏 分享 收藏 Consensus protocol for diagnosis and management of singleton pregnancies with vasa previa: interim findings from a Delphi studyOyelese, Y.; Javinani, A.; Lees, C.; Silver, R.; Odibo, A.; Akolekar, R.; Jauniaux, E.; Rebarber, A.; Prefumo, F.; D'Souza, R.; Catanzarite, V. A.; Hasegawa, J.; Tachibana, D.; Cincotta, R.; Duncombe, G.; Meltcer, Y.; Scheier, M. A.; Bronsteen, R.; Shainker, S. A.; Srinivasan, D.; Daly-Jones, E.; Shamshirsaz, A. 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png)
ANNALS OF ONCOLOGY.png)
OAAI